Indian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...

BofA Securities and Bandhan AMC Ltd. expect the Reserve Bank of India to step up short-term cash withdrawal operations in coming months as ...

The U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...

The Malayalam comedy-drama Aashaan, directed by Johnpaul George and starring Indrans in the lead role, is set to make its OTT debut soon. T...

Children in L'Hospitalet de Llobregat are struggling with unbearable classroom heat exceeding 29C, prompting a grassroots project to monito...

The week of June 15-21, 2026, features a powerful astrological shift with a Gemini New Moon and Sun transit on June 15, fostering new begin...

The IPO, the biggest in US history, vaulted SpaceX's value above two Mag 7 members: CEO Elon Musk's other company, Tesla , ⁠and ⁠Meta Platf...

SpaceX's massive $2 trillion IPO has challenged the 'Magnificent Seven' moniker, as its valuation now surpasses Tesla and Meta. With other ...

SpaceX IPO has set off a race to devise the next cool acronym. These groupings are not formal market categories, but shorthand labels coine...

Global challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...

The Sun transit in Gemini on June 15, 2026 brings a noticeable shift toward communication, networking, learning, adaptability, and new oppo...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....

Indian equities have lost Rs 4.5 lakh crore in 100 days as the Iran-led West Asia conflict and a global AI trade unwind trigger sharp FII o...

BofA Securities India's Amish Shah advises shifting from IT to infrastructure, citing a 'dangerous gap' in consensus earnings forecasts. He...

The Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...